Zaloguj Zarejestruj się zadarmo

Last updated: 31 January 2023 at 2:30pm EST

James Anderson Net Worth




The estimated Net Worth of James M. Anderson is at least $1.07 Milion dollars as of 6 January 2023. Mr. Anderson owns over 8,500 units of Meridian Bioscience stock worth over $958,769 and over the last 15 years he sold VIVO stock worth over $0. In addition, he makes $114,667 as Independent Director at Meridian Bioscience.

Mr. Anderson VIVO stock SEC Form 4 insiders trading

James has made over 3 trades of the Meridian Bioscience stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 8,500 units of VIVO stock worth $173,230 on 6 January 2023.

The largest trade he's ever made was buying 10,000 units of Meridian Bioscience stock on 1 June 2011 worth over $237,400. On average, James trades about 1,175 units every 212 days since 2009. As of 6 January 2023 he still owns at least 28,224 units of Meridian Bioscience stock.

You can see the complete history of Mr. Anderson stock trades at the bottom of the page.





James Anderson biography

James M. Anderson serves as Independent Director of the Company. He currently serves as Senior Strategic and External Affairs Advisor with Taft Stettinius & Hollister LLP and President Emeritus of Cincinnati Children’s Hospital Medical Center (“CCHMC”), after having served as advisor to the President of CCHMC from January 2010 through June 30, 2017 and as President and Chief Executive Officer of CCHMC from 1996 through 2009. Mr. Anderson serves on the Board of Managers of CincyTech, a firm that provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions to regional companies. From 2006 to 2014, he served as a director of Ameritas Mutual Holding Company and has also served as Chairman of the Board of the Cincinnati Branch of the Federal Reserve Bank of Cleveland, retiring in 2012. Prior to joining the staff of CCHMC, Mr. Anderson was a partner in the general corporate law department at Taft, Stettinius & Hollister for 24 years (1968-1977; 1982-1996) and president of U.S. operations at Xomox Corporation, a publicly-traded manufacturer of specialty process controls (1977-1982). Mr. Anderson has also served as director of Gateway Investment Advisors (1997-2008). The Board believes that Mr. Anderson’s corporate legal experience and his experience as CEO of a large health care organization have given him a wealth of insight into various corporate governance and business management issues, which, along with his status as an independent director, make him an integral member of the Board.

What is the salary of James Anderson?

As the Independent Director of Meridian Bioscience, the total compensation of James Anderson at Meridian Bioscience is $114,667. There are 7 executives at Meridian Bioscience getting paid more, with John P. Kenny having the highest compensation of $1,508,705.



How old is James Anderson?

James Anderson is 77, he's been the Independent Director of Meridian Bioscience since 2009. There are 1 older and 12 younger executives at Meridian Bioscience. The oldest executive at Meridian Bioscience Inc. is David Phillips, 81, who is the Independent Chairman of the Board.

What's James Anderson's mailing address?

James's mailing address filed with the SEC is 3471 RIVER HILLS DRIVE, , CINCINNATI, OH, 45244.

Insiders trading at Meridian Bioscience

Over the last 22 years, insiders at Meridian Bioscience have traded over $8,089,514 worth of Meridian Bioscience stock and bought 228,244 units worth $3,053,655 . The most active insiders traders include Richard Eberly, John P. Kenny oraz John A Kraeutler. On average, Meridian Bioscience executives and independent directors trade stock every 41 days with the average trade being worth of $424,761. The most recent stock trade was executed by James M. Anderson on 6 January 2023, trading 8,500 units of VIVO stock currently worth $173,230.



What does Meridian Bioscience do?

Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.



What does Meridian Bioscience's logo look like?

Meridian Bioscience Inc. logo

Complete history of Mr. Anderson stock trades at Meridian Bioscience

Data
#
Firma
 Osoba
Trans.
Transakcja
 Ilość akcji Cena za akcję Łączna cena Ilość akcji po Źródło
6 Jan 2023 VIVO Meridian Bioscience Inc. James M. Anderson
Dyrektor
 Opcja Ćwiczenie 8,500 $20.38 $173,230
6 Jan 2023
28,224 ↗
16 May 2019 VIVO Meridian Bioscience Inc. James M. Anderson
Dyrektor
 Kupować 5,000 $11.37 $56,850
16 May 2019
11,981 ↗
1 Jun 2011 VIVO Meridian Bioscience Inc. James M. Anderson
Dyrektor
 Kupować 10,000 $23.74 $237,400
1 Jun 2011
5,000 ↗


Meridian Bioscience executives and stock owners

Meridian Bioscience executives and other stock owners filed with the SEC include: